Clinical characteristics of non-perianal fistulating Crohn's disease in China: a single-center experience of 184 cases

被引:20
作者
Wang Ge-fei [1 ]
Ren Jian-an [1 ]
Liu Song [1 ]
Chen Jun [1 ]
Gu Guo-sheng [1 ]
Wang Xin-bo [1 ]
Fan Chao-gang [1 ]
Li Jie-shou [1 ]
机构
[1] Nanjing Univ, Sch Med, Dept Surg, Jinling Hosp, Nanjing 210002, Jiangsu, Peoples R China
关键词
Crohn's disease; non-perianal fistulae; inflammatory bowel disease; clinical feature; follow-up; INFLAMMATORY-BOWEL-DISEASE; LONG-TERM PROGNOSIS; MANAGEMENT; EPIDEMIOLOGY; EXPRESSION; DIAGNOSIS; FEATURES; SURGERY; RATES;
D O I
10.3760/cma.j.issn.0366-6999.2012.14.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background There is little information of non-perianal fistulating Crohn's disease in the consensus published by the European Crohn's and Colitis Organization in 2006 and 2010. This study was designed to demonstrate the clinical characteristics of non-perianal fistulating Crohn's disease among homogenous Chinese population. Methods One-hundred-and-eighty-four patients were retrospectively collected. All of these patients were diagnosed of Crohn's disease between February 2001 and April 2011. Results The male-to-female ratio was 2.7:1. The most common symptoms at onset were abdominal pain (88.0%), diarrhea (34.7%), and fever (28.3%). The most common disease location and behavior at diagnosis were small bowel (56.0%) and penetrating (51.6%). Among 324 non-perianal fistulae, the most common types were ileocolonic anastomotic (30.9%), terminal ileocutaneous (19.7%), and enteroenteric anastomotic (11.4%). One-hundred-and-thirty-eight (75.0%) patients received antibiotics, and beta-lactam (85.5%) and metronidazole (67.4%) are most frequently used. One-hundred-and-seventy-eight (96.7%) patients suffered 514 surgical operations, and the cumulative surgical rates after 1, 3, and 5 years were 38.0%, 52.2%, and 58.7% respectively. Nine patients died during the follow-up period, and the cumulative survival rates after 1, 3, and 5 years were 97.8%, 96.7%, and 96.2% respectively. Conclusions This study displayed the clinical characteristics of non-perianal fistulating Crohn's disease in our center. Large population-based studies are required for further investigation in China. Chin Med J 2012;125(14):2405-2410
引用
收藏
页码:2405 / 2410
页数:6
相关论文
共 22 条
  • [1] Risk factors for surgery and postoperative recurrence in Crohn's disease
    Bernell, O
    Lapidus, A
    Hellers, G
    [J]. ANNALS OF SURGERY, 2000, 231 (01) : 38 - 45
  • [2] The epidemiology of inflammatory bowel disease in Canada: A population-based study
    Bernstein, Charles N.
    Wajda, Andre
    Svenson, Lawrence W.
    MacKenzie, Adrian
    Koehoorn, Mieke
    Jackson, Maureen
    Fedorak, Richard
    Israel, David
    Blanchard, James F.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (07) : 1559 - 1568
  • [3] World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010
    Bernstein, Charles N.
    Fried, Michael
    Krabshuis, J. H.
    Cohen, Henry
    Eliakim, R.
    Fedail, Suleiman
    Gearry, Richard
    Goh, K. L.
    Hamid, Saheed
    Khan, Aamir Ghafor
    LeMair, A. W.
    Prof Malfertheiner
    Qin Ouyang
    Rey, J. F.
    Sood, Ajit
    Steinwurz, Flavio
    Thomsen, Ole O.
    Thomson, Alan
    Watermeyer, Gillian
    [J]. INFLAMMATORY BOWEL DISEASES, 2010, 16 (01) : 112 - 124
  • [4] European evidence based consensus on the diagnosis and management of Crohn's disease: special situations
    Caprilli, R
    Gassull, MA
    Escher, JC
    Moser, G
    Munkholm, P
    Forbes, A
    Hommes, DW
    Lochs, H
    Angelucci, E
    Cocco, A
    Vucelic, B
    Hildebrand, H
    Kolacek, S
    Riis, L
    Lukas, M
    de Franchis, R
    Hamilton, M
    Jantschek, G
    Michetti, P
    O'Morain, C
    Anwar, MM
    Freitas, JL
    Mouzas, IA
    Baert, F
    Mitchel, R
    Hawkey, CJ
    [J]. GUT, 2006, 55 : i36 - i58
  • [5] The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
    Dignass, A.
    Van Assche, G.
    Lindsay, J. O.
    Lemann, M.
    Soderholm, J.
    Colombel, J. F.
    Danese, S.
    D'Hoore, A.
    Gassull, M.
    Gomollon, F.
    Hommes, D. W.
    Michetti, P.
    O'Morain, C.
    Oresland, T.
    Windsor, A.
    Stange, E. F.
    Travis, S. P. L.
    [J]. JOURNAL OF CROHNS & COLITIS, 2010, 4 (01) : 28 - 62
  • [6] DU RY, 1984, CHINESE MED J-PEKING, V97, P317
  • [7] The epidemiology and phenotype of Crohn's disease in the Chinese population
    Leong, RWL
    Lau, JY
    Sung, JJY
    [J]. INFLAMMATORY BOWEL DISEASES, 2004, 10 (05) : 646 - 651
  • [8] Clinical course and longterm prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality
    Oriuchi, T
    Hiwatashi, N
    Kinouchi, Y
    Takahashi, S
    Takagi, S
    Negoro, K
    Shimosegawa, T
    [J]. JOURNAL OF GASTROENTEROLOGY, 2003, 38 (10) : 942 - 953
  • [9] Prantera C, 1998, ITAL J GASTROENTEROL, V30, P602
  • [10] Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-κB transcriptional activation
    Qiu, DM
    Zhao, GH
    Aoki, Y
    Shi, LF
    Uyei, A
    Nazarian, S
    Ng, JCH
    Kao, PN
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) : 13443 - 13450